Categories Other Industries, Technology

Qualcomm opts for mass layoffs as part of cost-cutting plan

Chipmaker Qualcomm (QCOM), which is trapped in the middle of the trade war between China and the US, is slashing headcount in an effort to cut costs. Qualcomm had set a financial target for 2019 during its hostile takeover battle with rival Broadcom (AVGO).

The company had said it expects adjusted EPS of about $6.75 to $7.50 for the next fiscal year. And in order to hit this financial projection, the chipmaker early this year unveiled a $1 billion cost-cutting plan.

Broadcom eventually backed out from the deal after President Trump ordered to block the merger due to national security concerns. But Qualcomm, since then, has been working aggressively to ramp up its operations to boost earnings.

Courtesy: Maurizio Pesce / Flickr

As a part of this new plan, the chipmaker is considering mass layoffs. However, the company did not specify how many jobs — full-time and temporary — are set to be axed.  But the layoffs are said to be on a large scale as the company plans to file a WARN (Worker Adjustment and Retraining Notification) notice with the state of California.

Qualcomm said it had evaluated various other strategies to trim costs, but later found job cuts to be crucial to boost long-term growth.

Similarly, in 2015, the company axed around 1,315 jobs as it reduced $1.4 billion in costs. Despite the layoffs, the company’s global workforce remained same at over 33, 000, partly due to the deals it made.

This news comes just days after the US Department of Commerce slapped a seven-year ban on Qualcomm over the sale of components to its major customer ZTE Corp. — a Chinese telecom equipment maker. This ban is said to affect the company’s revenues as it accounts for a major share of semiconductor chips that are used in ZTE smartphones.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top